GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 191 filers reported holding GENMAB A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $368,000 | -29.1% | 11,350 | -21.0% | 0.08% | -17.8% |
| Q1 2022 | $519,000 | -17.1% | 14,369 | -9.2% | 0.10% | -15.1% |
| Q4 2021 | $626,000 | -47.1% | 15,832 | -41.6% | 0.12% | -48.3% |
| Q3 2021 | $1,184,000 | -12.4% | 27,090 | -18.1% | 0.23% | -14.2% |
| Q2 2021 | $1,351,000 | -50.7% | 33,080 | -60.3% | 0.27% | -56.2% |
| Q1 2021 | $2,738,000 | -22.9% | 83,414 | -14.0% | 0.61% | -28.8% |
| Q3 2020 | $3,552,000 | +7.9% | 97,012 | -0.1% | 0.86% | +0.7% |
| Q2 2020 | $3,292,000 | – | 97,135 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |